| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/17/1996 | EP0706513A1 Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 04/17/1996 | EP0706512A1 Acetamide derivatives and their use for modifying feeding behaviour modifiers |
| 04/17/1996 | EP0706509A1 Short chain 2-hydroxycarboxylic acid-based derivatives of ceramides |
| 04/17/1996 | EP0706508A1 Anti-atherosclerotic diaryl compounds |
| 04/17/1996 | EP0706507A1 Salmeterol xinafoate with controlled particle size |
| 04/17/1996 | EP0706399A1 Compositions and process for removing bile salts |
| 04/17/1996 | EP0706398A1 Pharmaceutical composition containing heparin, heparin fragments or their derivatives in combination with glycerol esters |
| 04/17/1996 | EP0706396A1 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use |
| 04/17/1996 | EP0706395A1 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade |
| 04/17/1996 | EP0706394A1 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient |
| 04/17/1996 | EP0706393A1 Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone |
| 04/17/1996 | EP0706392A1 Use of rosmanol derivatives for producing antiradical and/or antilipoperoxidative and/or hepatotropic drugs |
| 04/17/1996 | EP0706390A1 Enhancing performance capacity by sparing muscle glycogen with medium chain fatty acids |
| 04/17/1996 | EP0706389A1 Amphoteric surfactant for the treatment of aphthous ulcers |
| 04/17/1996 | EP0706388A1 Pharmaceutical composition for immunomodulating and adjuvant treatment |
| 04/17/1996 | EP0706387A1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 04/17/1996 | EP0706386A1 Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders |
| 04/17/1996 | EP0706385A1 Use of isovaleramide as a mild anxiolytic and mild sedative agent |
| 04/17/1996 | EP0706384A1 Diamondoid derivatives for pharmaceutical use |
| 04/17/1996 | EP0706380A1 Encapsulated medicine |
| 04/17/1996 | EP0706378A1 New pharmaceutical formulation |
| 04/17/1996 | EP0706373A1 Liposome encapsulated taxol and a method of using the same |
| 04/17/1996 | EP0706370A1 Stable topical retinoid compositions |
| 04/17/1996 | EP0706319A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites |
| 04/17/1996 | EP0683665A4 Magnetically responsive composition for carrying biologically active substances and methods of production and use. |
| 04/17/1996 | EP0654028B1 3- and 5-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof, a pharmaceutical preparation containing said compounds and the use of said compounds for the preparation of medicaments |
| 04/17/1996 | EP0600952B1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| 04/17/1996 | EP0558673B1 Retroviral protease inhibitors |
| 04/17/1996 | EP0536329B1 R(+)-terazosin |
| 04/17/1996 | EP0493468B1 Anti-tumor preparation comprising interleukin-2 and histamine, analogs thereof or h2-receptor agonists |
| 04/17/1996 | EP0413828B1 Solid preparation of active vitamin d3 having improved stability |
| 04/17/1996 | CN1120843A 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity |
| 04/17/1996 | CN1120840A Pyrazolitriazines with interleukin-1 and tumour necrosis factor inhibitory activity |
| 04/17/1996 | CN1120838A Heterocyclic derivatives in the treatment of ischaemia and related diseases |
| 04/17/1996 | CN1120810A Agent for prophylaxis or treatment of cataract |
| 04/17/1996 | CN1120638A Cycloidal gear driving mechanism and apparatus |
| 04/17/1996 | CN1120543A Extraction, separation and purification of "jingu" mushroom holoside Ge and its inhibition effect on reverse-transcriptase of Aids virus |
| 04/17/1996 | CN1120541A New tetracyclic piperidine and 1,4-oxazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 04/17/1996 | CN1120538A 3-heteroaliphatyl- and 3-hetero (aryl) aliphatyl-2(1H)-quinolone dericatives |
| 04/17/1996 | CN1120537A Novel substituted sulphonic acid amide, preparation and pharmaceutical composition of same |
| 04/17/1996 | CN1120532A Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromones |
| 04/17/1996 | CN1120447A Rhinitis liniment and its prepn. |
| 04/17/1996 | CN1120436A A remedy for bronchial asthma |
| 04/17/1996 | CN1120434A Application of nodakenin and its relative compound in treatment of arrhythmia |
| 04/17/1996 | CN1120433A "Weiling" gastritis oral liquid and its prepn. method |
| 04/17/1996 | CN1120432A Anti inflammatory analgesic medicine and prepn. thereof |
| 04/17/1996 | CN1031574C Process for preparation of 4-amino-delta-4, 6-steroid(s) compounds |
| 04/17/1996 | CN1031570C Process for preparation of pyrazolopyridine compound |
| 04/17/1996 | CN1031564C Process for preparation of 4-|-(2-hydroxy-2-phenylethylamino)ethoxy¨ phenyl acet acid and its derivatives |
| 04/17/1996 | CN1031544C N-pheny-pyrazole derivatives |
| 04/16/1996 | USRE35213 Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration |
| 04/16/1996 | US5508426 Antiarthritic agent |
| 04/16/1996 | US5508424 Reduced side effects |
| 04/16/1996 | US5508419 Substituted triazoles as angiotensin II inhibitors |
| 04/16/1996 | US5508408 Leukotriene antagonists |
| 04/16/1996 | US5508406 For treating cardiovascular disorders |
| 04/16/1996 | US5508405 Quinuclidines, their use as medicaments and processes for their preparation |
| 04/16/1996 | US5508403 Enhances effects of antitumor agents |
| 04/16/1996 | US5508401 N-methyl-d-aspartate antagonists |
| 04/16/1996 | US5508399 Carbamates of rapamycin |
| 04/16/1996 | US5508397 Ascomycin immunosuppressant |
| 04/16/1996 | US5508392 Use of vitamin D glycosides, vitamin D orthoester glycosides, vitamin D analog glycosides and vitamin D analog orthoester glycosides for the treatment of osteoporosis |
| 04/16/1996 | US5508391 Nonhygroscopic, free-flowing, stable, water soluble |
| 04/16/1996 | US5508390 Diterpenes having immunomodulatory action |
| 04/16/1996 | US5508311 Aliphatic propargylamines as selective MAO-B inhibitors and as neuroprotective agents |
| 04/16/1996 | US5508310 Immunopotentiatory agents and physiologically acceptable salts thereof |
| 04/16/1996 | US5508308 Use of pyruvylglycine to treat ischemia/reperfusion injury following myocardial infarction |
| 04/16/1996 | US5508307 Administering lithium salts of fatty acids intravenously, monitoring plasma lithium levels to avoid hemolysis |
| 04/16/1996 | US5508306 Used for treatment of benign prostatic hyperplasia, lowering intraocular pressure and inhibiting cholesterol synthesis |
| 04/16/1996 | US5508305 2, 4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals |
| 04/16/1996 | US5508304 Administering skyrin analog to lower or maintain od blood glucose levels |
| 04/16/1996 | US5508303 Hair-growing composition |
| 04/16/1996 | US5508301 Ketorolac derivatives with considerably reduced gastro-intestinal irritation and ulceration |
| 04/16/1996 | US5508300 Inhibit phosphodiesterase and production of tumor necrosis factor; treating inflammatory diseases |
| 04/16/1996 | US5508299 Angiotensin converting enzyme inhibitor, arterial hypotensive agent; cardiovascular disorders |
| 04/16/1996 | US5508297 Vascular hypertrophy suppression treatment |
| 04/16/1996 | US5508294 Sulfonylalkanoylamino hydroxyethlamino sulfonamides useful as retroviral protease inhibitors |
| 04/16/1996 | US5508293 Treating hypertension, angina pectoris |
| 04/16/1996 | US5508292 Administering anticoagulants to humans to treat atherosclerotic diseases; cardiovascular disorders |
| 04/16/1996 | US5508290 Hindered N-oxide esters of rapamycin |
| 04/16/1996 | US5508289 Bis-acridone chemotherapeutic derivatives |
| 04/16/1996 | US5508288 Indole derivatives as 5HT1C antagonists |
| 04/16/1996 | US5508286 Rapamycin amidino carbamates |
| 04/16/1996 | US5508285 Hindered N-oxide esters of rapamycin |
| 04/16/1996 | US5508284 Treating 5-hydroxytryptamine modulation |
| 04/16/1996 | US5508282 Composition and method for treating acute or chronic rhinosinusitis |
| 04/16/1996 | US5508279 Increases urine flow while avoiding hypotensive effects |
| 04/16/1996 | US5508278 Bactericides |
| 04/16/1996 | US5508277 Administering to suppress tumor cell resistance to antineoplastic drugs |
| 04/16/1996 | US5508276 Having duloxetine core, hydroxypropyl methyl cellulose acetate succinate enteric layer |
| 04/16/1996 | US5508275 Lipid-selective antioxidants and their preparation and use |
| 04/16/1996 | US5508274 24R,25-dihydroxycholecalciferol to treat vitamin D resistant rickets |
| 04/16/1996 | US5508272 Compounds containing a fused bicycle ring and processes therefor |
| 04/16/1996 | US5508271 Treatment of neurological dysfunction with methylcobalamin |
| 04/16/1996 | US5508269 Aminoglycoside formulation for aerosolization |
| 04/16/1996 | US5508046 Microbiocides for surgical and dental instrument cosists of peracetic acid, acetic acid, hydrogen peroxide and aquous diluent, phosphoric acid and sodium pyrophosphate as stabilizers, free of metallic contamination and surfactants |
| 04/16/1996 | US5508045 Administering nitric oxide donor |
| 04/16/1996 | US5508044 Controlled release form and hydrochlorothiazide immediate release form; treatment of hypertension |
| 04/16/1996 | US5508042 Administering an oral dosage every 12 hours |
| 04/16/1996 | US5508039 Controlled transdermal administration of melatonin |